Mike Ralston, CEO of Blencowe Resources, explains the significance of the MSP for Orom-Cross. Watch the interview here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksGSP.L Regulatory News (GSP)

  • There is currently no data for GSP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR Dealings & Promissory Note Maturity Amendment

24 Apr 2023 07:00

RNS Number : 1290X
Gensource Potash Corporation
24 April 2023
 

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

 

Gensource Potash Announces PDMR Dealings and Amendment of Maturity of Promissory Note

  SASKATOON, Saskatchewan and London, U.K. - April 24, 2023 - Gensource Potash Corporation ("Gensource" or the "Company") (AIM/TSXV: GSP), a fertilizer development company focused on sustainable potash production, announces the transactions below by PDMR's in the Company's Common Shares and an amendment to the maturity date of the following promissory note (the "Promissory Note") issued to Michael Ferguson, CEO and a director of the Company:

· Promissory Note $250,000 principal amount outstanding

· Original Terms Unsecured and bears interest at a rate of 0% per annum

· Original Maturity Date July 1,2023

· Amended Maturity Date July 1, 2024

 

As the director is an insider of the Company, the amendment to the maturity date of the Promissory Note is deemed to be a "related party transaction" as defined under MI 61-101. The Company is exempt from the formal valuation and minority approval requirements for related party transactions pursuant to Subsection 5.5(a) and Subsection 5.7(a) of MI 61-101, respectively.

The Company varying the terms of the Promissory Note with Mr. Ferguson constitutes a related party transaction under Rule 13 of AIM Rules for Companies. The directors of the Company, other than Mr. Ferguson, confirm, having consulted with the Company's nominated adviser, Strand Hanson Limited, that they consider that the amendment to the maturity date of the Promissory Note to be fair and reasonable insofar as its shareholders are concerned.

Michael Ferguson, Executive Director, acquired 75,000 Common Shares on April 20, 2023, at $0.11 per Common Share, Stephen Dyer, Non-Executive Director, acquired 100,000 Common Shares on April 21, 2023 at C$0.12 per Common Share and Robert Theoret, Vice-President Finance & Business Development, acquired 50,000 Common Shares on April 19, 2023, at $0.10 per Common Share.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Michael Ferguson

2

Reason for the notification

a)

Position/status

Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Gensource Potash Corporation

b)

LEI

 213800WAVVOPS85N2205

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Gensource Potash Corp Common Shares

 

 

ISIN: CA3725X1042

b)

Nature of the transaction

The acquisition of common shares of no par value each in the Company

c)

Price(s) and volume(s)

 

Price

Volume

$0.11

75,000

d)

Aggregated information

-

Aggregated volume

-

Price

 

Same as above

e)

Date of the transaction

April 20, 2023

f)

Place of the transaction

TSX-V Exchange

 

As a result, Michael Ferguson's total beneficial interest in the Company is 17,947,708 Common Shares, representing 3.97 percent of the Company's issued share capital.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Stephen Dyer

2

Reason for the notification

a)

Position/status

Non-Exectuive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Gensource Potash Corporation

b)

LEI

 213800WAVVOPS85N2205

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Gensource Potash Corp Common Shares

 

 

ISIN: CA3725X1042

b)

Nature of the transaction

The acquisition of common shares of no par value each in the Company

c)

Price(s) and volume(s)

 

Price

Volume

$0.12

100,000

 

d)

Aggregated information

-

Aggregated volume

-

Price

 

Same as above

e)

Date of the transaction

April 21, 2023

f)

Place of the transaction

TSX-V Exchange

 

As a result, Stephen Dyer's total beneficial interest in the Company is 475,000 Common Shares, representing .11 percent of the Company's issued share capital.

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Robert Theoret

2

Reason for the notification

a)

Position/status

Vice-President Finance & Business Development

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Gensource Potash Corporation

b)

LEI

 213800WAVVOPS85N2205

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Gensource Potash Corp Common Shares

 

 

ISIN: CA3725X1042

b)

Nature of the transaction

The acquisition of common shares of no par value each in the Company

c)

Price(s) and volume(s)

 

Price

Volume

$0.10

50,000

 

d)

Aggregated information

-

Aggregated volume

-

Price

 

Same as above.

e)

Date of the transaction

April 19, 2023

f)

Place of the transaction

TSX-V Exchange

 

As a result, Robert Theoret's total beneficial interest in the Company is 10,080,750 Common Shares, representing 2.23 percent of the Company's issued share capital.

For further information on Gensource Potash, please contact:

 

Gensource Potash Corporation

 

Mike Ferguson - President & CEO

+1-306-974-6414

 

 

Strand Hanson Limited (Nominated & Financial Adviser)

+44 (0) 20 7409 3494

Ritchie Balmer / Rory Murphy / Charles Hammond

 

 

Peel Hunt LLP (Broker)

+44 (0) 20 7418 8900

Ross Allister / David McKeown / Georgia Langoulant

 

 

Camarco (Financial PR)

+44 (0) 20 3757 4997

Gordon Poole / Charlotte Hollinshead / Lily Pettifar

 

 

For any press enquiries please contact us on gensource@camarco.co.uk

 

Further information on Gensource Potash Corporation can be found at www.gensourcepotash.ca

Follow us on twitter @GensourcePotash

 

About Gensource

Gensource is a fertilizer development company based in Saskatoon, Saskatchewan and is on track to become the next fertilizer production company in that province. With a modular and environmentally leading approach to potash production, Gensource believes its technical and business model will be the future of the industry. Gensource operates under a business plan that has two key components: (1) vertical integration with the market to ensure that all production capacity built is directed, and pre-sold, to a specific market, eliminating market-side risk; and (2) technical innovation which will allow for a modular and economic potash production facility, that demonstrates environmental leadership within the industry, producing no salt tailings, therefore eliminating decommissioning risk, and requiring no surface brine ponds, thereby removing the single largest and negative environmental aspect of potash mining.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This news release may contain forward looking information and Gensource cautions readers that forward- looking information is based on certain assumptions and risk factors that could cause actual results to differ materially from the expectations of Gensource included in this news release. This news release includes certain "forward-looking statements", which often, but not always, can be identified by the use of words such as "believes", "anticipates", "expects", "estimates", "may", "could", "would", "will", or "plan". These statements are based on information currently available to Gensource and Gensource provides no assurance that actual results will meet management's expectations.

Forward looking statements include estimates and statements with respect to Gensource's future plans, objectives or goals, to the effect that Gensource or management expects a stated condition or result to occur, including any offering of securities by Gensource. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated in such statements for many reasons such as: failure to receive final approval of the TSX Venture Exchange and any other approvals for the extension of the Promissory Note; failure to finance the Tugaske Project or other projects on terms which are economic or at all; failure to settle a definitive joint venture agreement with a party and advance and finance the Tugaske Project; changes in general economic conditions and conditions in the financial markets; the ability to find and source off-take agreements; changes in demand and prices for potash; litigation, legislative, environmental and other judicial, regulatory, political and competitive developments; technological and operational difficulties encountered in connection with Gensource's activities; an inability to predict and counteract the effects of COVID-19 on the business of Gensource, including but not limited to the effects of COVID-19 on the price of commodities, capital market conditions, restriction on labour and international travel and supply chains, failure to obtain required regulatory approvals; and other matters discussed in this news release and in filings made with securities regulators. This list is not exhaustive of the factors that may affect any of Gensource's forward-looking statements. These and other factors should be considered carefully, and readers should not place undue reliance on Gensource's forward-looking statements. Gensource does not undertake to update any forward-looking statement that may be made from time to time by Gensource or on its behalf, except in accordance with applicable securities laws.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGZGZDRMZGFZM
12
Date   Source Headline
1st Jul 20247:00 amRNSCancellation - Gensource Potash Corporation
26th Jun 20247:00 amRNSDirector/PDMR Shareholding
25th Jun 20247:00 amRNSDirector/PDMR Shareholding
17th Jun 20247:00 amRNSDirector/PDMR Shareholding
30th May 20247:00 amRNSResignation of Advisor & Related Party Transaction
29th May 20247:30 amRNSSuspension - Gensource Potash Corporation
30th Apr 20247:00 amRNSFinal Results
7th Dec 20237:00 amRNS3D Seismic Program and Comprehensive Update
2nd Oct 20237:00 amRNSClosing of Non-Brokered Private Placement and TVR
28th Sep 20237:00 amRNS$700,000 Non-Brokered Private Placement
30th Aug 20237:01 amRNSFinancial Statements and Management's Discussion
26th Jul 20237:00 amRNSPDMR Dealing
4th Jul 20237:00 amRNSResults of AGM and Amendments to Articles
5th Jun 20237:00 amRNSConvertible Debentures & Granting of Stock Options
30th May 20237:00 amRNSClosing of Non-Brokered Private Placement and TVR
26th May 20237:00 amRNSMailing of Information Circular
25th May 20237:00 amRNSCompletion of Nominated Adviser Due Diligence
22nd May 20237:00 amRNS$800,000 Non-Brokered Private Placement
9th May 20232:32 pmRNSGranting of Stock Options
4th May 202312:00 pmRNSAppointment of Director
24th Apr 20237:00 amRNSPDMR Dealings & Promissory Note Maturity Amendment
14th Apr 20237:00 amRNSDirector Resignation
3rd Apr 20237:00 amRNSFinal Results
23rd Feb 20237:00 amRNSStrategic Business Relationship and Project Update
14th Feb 20237:00 amRNSDirector Dealing
27th Jan 20237:00 amRNSClosing of Non-Brokered Private Placement & TVR
19th Jan 20237:00 amRNS2022 Year-end Update and Outlook for 2023
3rd Jan 20237:00 amRNSClosing of Non-Brokered Private Placement and TVR
1st Dec 20227:00 amRNS$6,000,000 Non-Brokered Private Placement
29th Nov 20227:00 amRNSFinancial Statements and Management's Discussion
13th Sep 20227:00 amRNSAIM Rules Related Party Transaction Opinion
30th Aug 20227:00 amRNS2nd Quarter Results
26th Aug 20227:00 amRNSShareholder Update Call
29th Jul 20227:00 amRNSGensource Potash Announces Director Dealing
25th Jul 20227:55 amRNSDirector Dealing
12th Jul 20227:00 amRNSChange of Registered Office
21st Jun 20227:00 amRNSHelm update and Intention to Increase Capacity
14th Jun 20227:00 amRNSDirector/PDMR Exercise of Options and Dealing
13th Jun 20227:00 amRNSGensource Potash Announces Director Dealing
31st May 20227:00 amRNSShareholder Meeting, Q1s + New Board Chair
26th May 20227:23 amRNSGensource Completes First On-Site Activities
13th Apr 20227:00 amRNSAgreement to Acquire Innovare Technologies Ltd.
1st Apr 20227:00 amRNSGensource Renews Investor Relations Contract
28th Mar 20227:08 amRNSFinal Results
28th Mar 20227:00 amRNSPotash Market / Company Update & 2021 Financials
14th Feb 20227:00 amRNSGensource Announces Settlement of Legal Claim
14th Feb 20227:00 amRNSGensource Announces Exercise of Stock Options
27th Jan 20227:00 amRNS2021 Year End Review and 2022 Outlook
21st Jan 20229:00 amRNSInvestor Presentation
21st Dec 20217:00 amRNSGensource Announces Increase in Potash Asset Base
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Track Your Investments

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.